Europe Preclinical Imaging Market Size & Outlook, 2026-2033
Global Report
Related Markets
Europe preclinical imaging market highlights
- The Europe preclinical imaging market generated a revenue of USD 276.3 million in 2025.
- The market is expected to grow at a CAGR of 5.7% from 2026 to 2033.
- In terms of segment, modality was the largest revenue generating type in 2025.
- Service is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 276.3 million |
| Market revenue in 2033 | USD 428.9 million |
| Growth rate | 5.7% (CAGR from 2026 to 2033) |
| Largest segment | Modality |
| Fastest growing segment | Service |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modality, Reagent, Service |
| Key market players worldwide | Bruker Corp, Siemens AG, GE Aerospace, PerkinElmer, FUJIFILM Holdings Corp, Agilent Technologies, Rigaku, TriFoil Imaging, Mediso Medical Imaging Systems, MR Solutions |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.2% of the preclinical imaging market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 376.0 million by 2033.
Europe is one of the most developed regions in the world. Increasing public and private investments in R&D are some of the significant factors contributing to its market growth. Rising demand for healthcare devices and growing prevalence of chronic disorders & pain-associated disorders in the region are some major drivers anticipated to propel regional market growth.
Increasing demand for advanced technologies and rising health awareness are some other key factors expected to boost market growth. In addition, the research laboratories are looking to reduce operational costs, which is leading to the adoption of imaging in preclinical trials.
Most of the European countries, such as France, the UK, and Germany, have a high per capita income and well-defined healthcare policies that facilitate improved diagnostic systems. Increase in aging population in these countries is propelling the demand for advanced healthcare facilities such as MRI.
No credit card required*
Publish Date: Jan 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Preclinical Imaging Market Scope
Preclinical Imaging Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Siemens AG | View profile | 321,000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | www.siemens.com |
| GE Aerospace | View profile | 125,000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | www.geaerospace.com |
| FUJIFILM Holdings Corp | View profile | 83,784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | www.fujifilmholdings.com |
| Bruker Corp | View profile | 9,707 | 40 Manning Road, Billerica, MA, United States, 01821 | www.bruker.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Rigaku | View profile | 501-1000 | Akishima, Tokyo, Japan, Asia | japan.rigaku.com/ja |
| Agilent Technologies | View profile | 10001+ | Santa Clara, California, United States, North America | www.agilent.com |
| Mediso Medical Imaging Systems | View profile | 251-500 | Budapest, Budapest, Hungary, Europe | mediso.com/ |
| TriFoil Imaging | View profile | 11-50 | Chatsworth, California, United States, North America | www.trifoilimaging.com |
| MR Solutions | View profile | 101-250 | Guildford, Surrey, United Kingdom, Europe | www.mrsolutions.com/ |
Europe Preclinical Imaging Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Preclinical Imaging Market Outlook will help companies and investors design strategic landscapes.
Modality was the largest segment with a revenue share of 67.57% in 2025.
Horizon Databook has segmented the Europe preclinical imaging market based on modality, reagent, service covering the revenue growth of each sub-segment from 2021 to 2033.
Europe is one of the most developed regions in the world. Increasing public and private investments in R&D are some of the significant factors contributing to its market growth. Rising demand for healthcare devices and growing prevalence of chronic disorders & pain-associated disorders in the region are some major drivers anticipated to propel regional market growth.
Increasing demand for advanced technologies and rising health awareness are some other key factors expected to boost market growth. In addition, the research laboratories are looking to reduce operational costs, which is leading to the adoption of imaging in preclinical trials.
Most of the European countries, such as France, the UK, and Germany, have a high per capita income and well-defined healthcare policies that facilitate improved diagnostic systems. Increase in aging population in these countries is propelling the demand for advanced healthcare facilities such as MRI.
- Europe Preclinical Imaging Market Type Outlook (Revenue, USD Million , 2021-2033)
- Modality
- Reagent
- Service
- Europe Preclinical Imaging Market Application Outlook (Revenue, USD Million , 2021-2033)
- Drug Discovery & Development
- Toxicology & Pharmacokinetics Studies
- Basic & Translational Research
- Disease Mechanism & Pathophysiology Studies
- Biomarker & Imaging Agent Validation
- Others Application
- Europe Preclinical Imaging Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharma and Biotech Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others End Use
Reasons to subscribe to Preclinical Imaging Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Preclinical Imaging Market Outlook databook
- Our clientele includes a mix of Preclinical Imaging Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Preclinical Imaging Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Preclinical Imaging Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Preclinical Imaging Market, 2021-2033 (US$M)
Europe Type - Preclinical Imaging Market Statistics, 2025 - 2033 (US$M)
